Yusho Ishii ,James Rose,Kevin Cashman, Sakeenah Hicks, Christopher Scharer, Scott Jenks, Jeremy Boss,Iñaki Sanz
ICW33-4 Clinically inactive SLE resting naïve B cells retains abnormal transcriptome and epigenome
第68回日本リウマチ学会総会・学術集会 2024/4/18~4/20 神戸
Soshi Okazaki,Tsuyoshi Shirai,Tomonori Ishii,Hiroko Sato,Hiroshi Fujii
ICW29-6 Anti-EPCR antibodies found MEMO in Takayasu arteritis could connect vascular and intestinal inflammation
第68回日本リウマチ学会総会・学術集会 2024/4/18~4/20 神戸
K. Mori, T. Shirai, M. Narita, Y. Hoshi, T. Machiyama, H. Sato, T. Ishii, H. Fujii
A FATAL CASE OF VANISHING BILE DUCT SYNDROME FOLLOWING THE REMISSION INDUCTION THERAPY USING AVACOPAN FOR MICROSCOPIC POLYANGIITIS
EULAR 2024 CONGRESS 12 –15 JUNE , in Vienna
T. Shirai, M. Yamato, Y. Ishii, H. Sato, T. Ishii, H. Fujii
PATIENT SATISFACTION OF SUBCUTANEOUS BELIMUMAB AND IMPACT ON DISEASE ACTIVITY AND LUPUS NEPHRITIS IN LONG-LASTING SYSTEMIC LUPUS ERYTHEMATOSUS
EULAR 2024 CONGRESS 12 –15 JUNE , in Vienna
白井 剛志
高安動脈炎と潰瘍性大腸炎における抗EPCR抗体
A novel autoantibody against EPCR in Takayasu arteritis and ulcerative colitis
第112回日本病理学会総会 2023年4月13日(木)・14日(金)・15日(土) 下関市生涯プラザ 海峡メッセ下関
Ken Yasaka, Tomohide Yamazaki, Hiroko Sato, Tsuyoshi Shirai, Hiroshi Fujii,Tomonori Ishii, Hideo Harigae
Phospholipase D 4 Is a Novel Surface Marker of a Distinctive B Cell Population Overlapping with Double Negative 2 B Cells
ACR Convergence 2022, November 10–14 at the Pennsylvania Convention Center in Philadelphia,
Ryo Kuwata, Yuko Shirota, Tsuyoshi Shirai, Hiroyuki Yamashita, Hiroko Sato, Tomoki Takeda, Yumiko Oka, Takao Kodera, Hiroshi Kaneko, Junichi Kameoka, Hiroshi Fujii, Tomonori Ishii
Advantages and Disadvantages in Applying 2022 ACR/EULAR Classification Criteria to Conventionally Diagnosed Japanese GPA Patients
ACR Convergence 2022, November 10–14 at the Pennsylvania Convention Center in Philadelphia, Poster Session A
2021年
秋田佳奈恵、白井剛志、丹野唯人、高橋美岐、岡崎創司、星陽介、佐藤紘子、藤井博司、石井智徳、張替秀郎
若手リウマチ医奨励賞受賞者セッション
シクロホスファミドとアザチオプリンによる寛解維持が困難でインフリキシマブが有効であった再発性多発軟骨炎の一例
第30回日本リウマチ学会北海道東北支部学術集会 2021/2/13-14 WEB
高澤德彦、石井智徳、安藤重輝、亀岡淳一、佐々木毅
IgA腎症へのステロイドパルス療法後、寛解状態が持続する関節リウマチの1例
第30回日本リウマチ学会北海道東北支部学術集会 2021/2/13-14 WEB 口演
丹野唯人、高橋美岐、岡崎創司、星陽介、秋田佳奈恵、町山智章、佐藤紘子、白井剛志、藤井博司、石井智徳、張替秀郎
トシリズマブ、サリルマブで加療を行ったTAFRO症候群の一例
第30回日本リウマチ学会北海道東北支部学術集会 2021/2/13-14 WEB 口演
髙橋幹弘、岡崎創司、秋田佳奈恵、石井悠翔、丹野唯人、高橋美岐、星陽介、白井剛志、石井智徳、藤井博司、張替秀郎
SLESjogren症候群を伴う肺多発結節影を来した肺MALTlymphomaの一例
第30回日本リウマチ学会北海道東北支部学術集会 2021/2/13-14 WEB 口演
Tomoyuki Mutoh、Tsuyoshi Shirai、Tomonori Ishii、Yuko Shirota、Hideo Harigae、Hiroshi Fujii
ICW11-5 Pathogenic potential of novel autoantibodies in Takayasu arteritis
第64回日本リウマチ学会総会・学術集会 2020/8/17-9/15 WEB開催
Kanae Akita、Tsuyoshi Shirai、Tomonori Ishii、Hideo Harigae、Hiroshi Fujii
ICW16-6 Effects of IFN alpha-priming on B cell activation and actions of the FOXM1 inhibitor on activated B cells
第64回日本リウマチ学会総会・学術集会 2020/8/17-9/15 WEB開催
Tomoyuki Mutoh、Tsuyoshi Shirai、Tomonori Ishii、Yuko Shirota、Hideo Harigae、Hiroshi Fujii
ICW11-5 Pathogenic potential of novel autoantibodies in Takayasu arteritis
第64回日本リウマチ学会総会・学術集会 2020/8/17-9/15 WEB開催
Kanae Akita、Tsuyoshi Shirai、Tomonori Ishii、Hideo Harigae、Hiroshi Fujii
ICW16-6 Effects of IFN alpha-priming on B cell activation and actions of the FOXM1 inhibitor on activated B cells
第64回日本リウマチ学会総会・学術集会 2020/8/17-9/15 WEB開催
Tomoyuki Mutoh, Tsuyoshi Shirai, Hiroshi Fujii,Tomonori Ishii, Hideo Harigae
Endothelial protein C receptor and scavenger receptor class B type 1 are major autoantigens in Takayasu arteritis.
第63回日本リウマチ学会総会・学術集会 International Concurrent Workshop
2019/4/15-17 国立京都国際会館 口演
山崎智英、藤井博司、趙 晶、田中智香、上間徳之、流川俊満、山下結子、小幡千枝、石井智徳
pDC-specific Ab targeting PLD4 is a potential therapeutic Ab for SLE
ワークショップ8筋骨格系の免疫
第47回日本臨床免疫学会総会 2019/10/17-19 ロイトン札幌
Yusho lshii
Methionine adenosyltransferase modulates class switch recombination through epigenetic modification
第48回日本免疫学会学術集会 2019/12/11-13 アクトシティ浜松 ポスター
Tsuyoshi Shirai, Tomoyuki Muto, Yuko Shirota1, Hiroshi Fujii1, Tomonori Ishii3 and Hideo Harigae1,
High Prevalence of Vascular Surgery and Autoimmune Comorbidity in Takayasu Arteritis
2019 ACR/ARP Annual Meeting 2019/11/8-13 Georgia World Congress Center Atlanta,GA
Tomoyuki Mutoh,Tsuyoshi Shirai, Tomonori lshii, Yuko Shirota,Hideo Harigae,Hirohi Fujii
Endothelial protein C receptor and scavenger receptor class B type 1 negatively regulate vascular inflammation and are major autoantigens in Takayasu arteritis
2019 ACR/ARP Annual Meeting 2019/11/8-13
Georgia World Congress Center Atlanta,GA
Yusho Ishii, Hiroshi Fujii, Yosuke Hoshi, Yoko Fujita, Tsuyoshi Shirai, Yuko Shirota,
Tomonori Ishii, Hideo Harigae
Immunosuppresant therapies for a systemic sclerosis patient with anti-centriole antibody
5th Systemic Sclerosis World Congress Febrary 15-17,2018 in Bordeauxボルドー(France) ポスター
Yukiko Kamogawa, Hiroshi Fujii, Tsuyoshi Shirai, Tomonori Ishii, Hideo Harigae
Molecular mechanism for the therapeutic effect of extracorporeal shock wave therapy on digital ulcers of sysytemic sclerosis
5th Systemic Sclerosis World Congress Febrary 15-17,2018 in Bordeauxボルドー(France) ポスター
Tomonoro Ishii, Yukiko Kamogawa, Hiroshi Fujii, Yuko Shirota, Tsuyoshi Shirai,
Yoko Fujita
Non-randomized controlled trial to evaluate the effect of extracorporeal shock wave therapy on digital ulcers in systemic sclerosis.
5th Systemic Sclerosis World Congress Febrary 15-17,2018 in Bordeauxボルドー(France) ポスター
Tsuyoshi Shirai, Hiroshi Fujii, Yuko Shirota, Tomonori Ishii, Hideo Harigae
Four distant clinical phenotypes of vasculitis affecting medium-sized arteries.
EULAR2018: Annual European Congress of Rheumatology June 13-16,2018 in Amsterdum (Netherlands)
Tsuyoshi Shirai, Tomoyuki Muto, Yuko Shirota, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae,
High Prevalence of Vascular Surgery and Autoimmune Comorbidity in Takayasu Arteritis
2018 ACR/ARHP Annual Meeting、 Chicago, 10/19-24 ポスター
Tomoyuki Muto, Tsuyoshi Shirai, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae, Insufficient Use of Corticosteroids Results in Higher Relapse in Takayasu Arteritis
2018 ACR/ARHP Annual Meeting、 Chicago, 10/19-24 ポスター
Yoshikazu Nakaoka, Mutsuaki Isobe ,Syuji Takei, Yoshiya Tanaka, Tomonori Ishii, Shumpei Yokota, Akira Nomura, Seitaro Yoshida, Norihiro Nishimoto
Long-Term Efficacy and Safety of Tocilizmab in Patients With Refractory Takayasu Arteritis Treated Continuously over 52 weeks:Results from Phase 3, Randomized,Double Blind,Placebo-Controlled Trial and Open-Label Extensyon in Japan
2017ACR/ARHP Annual Meeting November 3-8, 2017 in San Diego、CA
口頭(セッション)
Tsuyoshi Shirai, Hiroshi Fujii, Yoko Fujita, Yuko Shirota, Tomonori Ishii, Hideo Harigae
Four-Distinct Phenotypes of Patients with Necrotizing Arteritis of Medium and Small Arterise
2017ACR/ARHP Annual Meeting November 3-8, 2017 in San Diego、CA ポスター
Tomonori Ishii,Yasushi Kawaguchi, Osamu Ishikawa ,Naruhiko Takasawa, Takao Kidera, Hidekata Yasuoka, Yuichi Takahashi, Osamu Takai, Izaya Nakaya, Hiroshi Fujii, Yukiko Kamogawa, Yuko Shirota, Tsuyoshi Shirai, Yoko Fujita, Shinichiro Saito, Hiroaki Shimokawa, Hideo Harigae
Non-Randomized Controlled Trial to Evaluate the Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers in Systemic Sclerosis
2017ACR/ARHP Annual Meeting November 3-8, 2017 in San Diego、CA ポスター
Yukiko Kamogawa, Hiroshi Fujii, Tsuyoshi Shirai, Tomonoti Ishii, Hideo Harigae
Molecular Mechanism for the Therapeutic Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers of Systemic Sclerosis
2017ACR/ARHP Annual Meeting November 3-8, 2017 in San Diego、CA ポスター
藤井博司、能勢眞人、武藤智之、秋田佳奈恵、鴨川由起子、藤田洋子、城田祐子、石井智徳、張替秀郎
Longer suppression of anti dsDNA antibody by sequential therapy with bortezomib and cyclophosphamide in lupus model mouse
第60回日本リウマチ学会総会・学術集会 2016.4.21-23 パシフィコ横浜
Tsuyoshi Shirai
An effective method to indentify autoantigens expressed on the cell surface:SARF
The 13th International Workshop on Autoantiboies and Autoimmunity(IWAA2016)
2016.10.11-13 京都 ポスター発表
Hiroshi Fujii, Tomoko Ikeda, Masato Nose, Tomoyuki Muto, Kanae Akita, Yukiko Kamogawa, Tsuyoshi Shirai, Yuko Shirota, Tomonori Ishii, Hideo Harigae
Bortezomib Treatment Induces Higher Mortality Rate in Lupus Model Mice with High Disease Activity
2016 ACR/ARHP Annual Meeting November 11-16, 2016 in Washington, DC
Yuko Shirota, Katsutoshi Furukawa, Manabu Tashiro, Tsuyoshi Shirrai, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae,
Positron Emission Tomography Images with an Amyloid-Specific Tracer 11C-BF-227 in Systemic Amyloidosis Patients
2016 ACR/ARHP Annual Meeting November 11-16, 2016 in Washington, DC
Tsuyoshi Shirai, Hiroshi Fujii, Tomoyuki Muto, Yuko Shirota, Yoko Fujita, Tomonori Ishii , Hideo Harigae
Establishment of a Powerful Method to Identify Autoantigens Expressed on the Cell Surface
2016 ACR/ARHP Annual Meeting November 11-16, 2016 in Washington, DC
Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei, Yoshiya Tanaka, Tomonori Ishii, Shumpei Yokota, Akira Nomura, Seitaro Yoshida , Norihiro Nishimoto
Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan. November 11-16, 2016 in Washington, DC 2016 ACR/ARHP Annual Meeting
Shinsuke Yasuda, Kazumasa Ohmura, Hiroshi Kanazawa, Takashi Kurita1, Yujiro Kon, Tomonori Ishii, Satoshi Jodo, Kazuhide Tanimura, Michio Minami, Tomomasa Izumiyama, Takumi Matsumoto, Yoshiharu Amasaki, Yoko Suzuki, Hideki Kasahara, Naofumi Yamauchi, Akito Tsutsumi, Hiromitsu Takemori, Takao Koike,Tatsuya Atsumi.
Maintenance Treatment Using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) – a Prospective, Multicentered, Single Arm Clinical Trial.
November 11-16, 2016 in Washington, DC 2016 ACR/ARHP Annual Meeting
Tomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, Kazuyoshi Saito, Kunihiro Ichinose, Yuko Shirota, Hiroshi Fujii, Yoko Fujita, Yukiko Kamogawa, Tomoaki Machiyama, Kanae Akita and Hideo Harigae
The First Randomized Control Trial to Evaluate the Effectiveness of Bortezomib for Refractory Systemic Lupus Erythematosus
ACR/ARHP Annual Meeting, November 6-11, 2015, San Francisco, CA
S.Saito, Y.Kamogawa, K.Nakamura, R.Watanabe, Y.Fujita, T.Shirai, Y.Shirota, H.Fujii, T.Ishii, K.Ito, H.Shimosegawa, H.Takemori, T.Konta, A.Komatsuda, T.Izumiyama, Y.Hirabayashi, Y.Sato, Y.Urata, Y.Kawaguchi, H.Harigae
Fate of collagen disease related digital skin ulcers treated only under currently approved therapies: A control study comparing with the new shockwave therapy toward digital ulcers of scleroderma
Annual European Congress of Rheumatology Paris, France, 11-14 June 2014
Tomoaki Machiyama, Kanae Akita, Yukiko Kamogawa, Ryu Watanabe, Yoko Fujita, Yuko Shirota, Shinichiro Saito, Tomonori Ishii and Hideo Harigae
Circulating CD19+CD38+CD43+ B Cell Subset in SLE Patients Have More Cell Cycle Related Genes Than Healthy Controls
ACR/ARHP Annual Meeting November 14-19,2014 Boston, MA
Hitoshi Kohsaka, Kosuke Kotani, Tomonori Ishii, Tomoya Miyamura, Masato Okada, Toshihiko Aranishi, R. Maciuca, William P. Kennedy and Junko Ohata
Interferon Gene Signature Expression and Serological Differences in Japanese and Non-Japanese SLE Patients
ACR/ARHP Annual Meeting , November 14-19, 2014 Boston, MA
Copyright (C) 東北大学大学院医学系研究科 臨床免疫学分野 / 東北大学病院 リウマチ膠原病内科 All Rights Reserved.